HomeAI · summaries
Storia in 2 fonti
New research aims to get closer to settling the fierce debate over what GLP-1s are worth
As a new Medicare program expands access to weight-loss drugs, high costs leave many who could benefit from them shut out.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
nbcnews.com
New research aims to get closer to settling the fierce debate over what GLP-1s are worth
As a new Medicare program expands access to weight-loss drugs, high costs leave many who could benefit from them shut out.
- ·
cnbc.com
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it
Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.